Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation

S. Dhein, S. Rothe, A. Busch, D. M. Rojas Gomez, A. Boldt, A. Reutemann, T. Seidel, A. Salameh, B. Pfannmüller, A. Rastan, M. Kostelka, F. W. Mohr

Resultado de la investigación: Contribución a una revistaArtículo

26 Citas (Scopus)

Resumen

BACKGROUND AND PURPOSE We investigated the influence of metoprolol on gap junction proteins connexin43 (Cx43) and connexin40 (Cx40) in atrial tissue from patients with/without atrial fibrillation (AF). EXPERIMENTAL APPROACH Left atrial tissue samples from 160 patients with AF or sinus rhythm (SR) with or without metoprolol (mean daily dose: 65.2 ± 9.1 mg·day -1) were analysed for Cx43 and Cx40 by Western blot and immunohistology. Transverse and longitudinal conduction velocities were determined by 64 multi-electrode mapping. KEY RESULTS Both Cx43 and Cx40 expression were significantly increased in patients with AF versus SR. Cx43-expression in AF was significantly higher in patients receiving metoprolol, while Cx40 expression was unaffected by metoprolol treatment. In AF, the ratio of lateral/polar expression of Cx43 and Cx40 was enhanced due to increased expression at the sides of the cells (lateral) and a loss at the cell poles. This AF-induced increase in lateral/polar expression of Cx43, but not of Cx40, was significantly antagonized by metoprolol treatment. Functionally, in AF patients, transverse conduction velocity in atrial samples was significantly enhanced and this change was also significantly antagonized by metoprolol. CONCLUSIONS AND IMPLICATIONS AF induced enhanced lateral expression of Cx43 and Cx40 together with enhanced transverse conduction velocity in left atrial tissue. Alterations in localization of Cx43 and conduction changes were both antagonized by metoprolol, showing that pharmacological modulation of gap junction remodelling seems, in principle, possible. This finding may open new approaches to the development of anti-arrythmic drugs.

Idioma originalInglés
Páginas (desde-hasta)607-616
Número de páginas10
PublicaciónBritish Journal of Pharmacology
Volumen164
N.º2 B
DOI
EstadoPublicada - 1 sep 2011

Áreas temáticas de ASJC Scopus

  • Farmacología

Huella Profundice en los temas de investigación de 'Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation'. En conjunto forman una huella única.

  • Citar esto

    Dhein, S., Rothe, S., Busch, A., Rojas Gomez, D. M., Boldt, A., Reutemann, A., Seidel, T., Salameh, A., Pfannmüller, B., Rastan, A., Kostelka, M., & Mohr, F. W. (2011). Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. British Journal of Pharmacology, 164(2 B), 607-616. https://doi.org/10.1111/j.1476-5381.2011.01460.x